Oncoustic
Toronto, CA · 25 employees on LinkedIn · 7 known investors
Oncoustics develops ultrasound-based artificial intelligence and machine learning solutions for cancer detection and liver disease characterization, serving clinical researchers and healthcare providers. The company operates research collaborations with Stanford University, University of Toronto, and international health institutes across Toronto, Cairo, and Palo Alto.
Founders & leadership


Investors · 7
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$5M disclosed across 1 round · 2022
- $5Mseed roundJul 2022 · 3 sources
Creative Ventures (lead), Saltagen Ventures (lead), Fraser Kearney Capital Corp., NorthSpring Capital Partners, Pallasite Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 4
by search overlapCompanies competing with Oncoustic for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Oncoustic do?
- Oncoustics develops ultrasound-based artificial intelligence and machine learning solutions for cancer detection and liver disease characterization, serving clinical researchers and healthcare providers. The company operates research collaborations with Stanford University, University of Toronto, and international health institutes across Toronto, Cairo, and Palo Alto.
- Who founded Oncoustic?
- Oncoustic was founded by Ahmed El Kaffas.
- Who are Oncoustic's investors?
- Oncoustic's investors include Creative Ventures, Pallasite Ventures, Saltagen Ventures, Sony Ventures Corporation, UCeed Funds.
- How much funding has Oncoustic raised?
- Oncoustic has disclosed $5M raised across 1 round.
- Where is Oncoustic headquartered?
- Oncoustic is headquartered in Toronto, CA.



